Platinum Investment Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-840,052
| Closed | -$1.85M | – | 120 |
|
|
2024
Q4 | $1.85M | Sell |
840,052
-252,810
| -23% | -$556K | 0.11% | 62 |
|
|
2024
Q3 | $1.8M | Sell |
1,092,862
-103,664
| -9% | -$171K | 0.08% | 69 |
|
|
2024
Q2 | $2.66M | Sell |
1,196,526
-401,016
| -25% | -$890K | 0.11% | 59 |
|
|
2024
Q1 | $4.28M | Sell |
1,597,542
-1,213,013
| -43% | -$3.25M | 0.17% | 47 |
|
|
2023
Q4 | $8.4M | Sell |
2,810,555
-378,962
| -12% | -$1.13M | 0.34% | 42 |
|
|
2023
Q3 | $3.13M | Sell |
3,189,517
-280,117
| -8% | -$275K | 0.12% | 61 |
|
|
2023
Q2 | $4.82M | Buy |
3,469,634
+889,059
| +34% | +$1.24M | 0.17% | 56 |
|
|
2023
Q1 | $4.1M | Buy |
2,580,575
+1,150,574
| +80% | +$1.83M | 0.14% | 64 |
|
|
2022
Q4 | $8.91M | Hold |
1,430,001
| – | – | 0.34% | 41 |
|
|
2022
Q3 | $9.58M | Sell |
1,430,001
-193,439
| -12% | -$1.3M | 0.4% | 41 |
|
|
2022
Q2 | $10.3M | Sell |
1,623,440
-1,089,736
| -40% | -$6.93M | 0.39% | 40 |
|
|
2022
Q1 | $12.6M | Hold |
2,713,176
| – | – | 0.39% | 39 |
|
|
2021
Q4 | $13.6M | Buy |
2,713,176
+1,000,000
| +58% | +$5M | 0.38% | 39 |
|
|
2021
Q3 | $20.6M | Hold |
1,713,176
| – | – | 0.58% | 32 |
|
|
2021
Q2 | $36.2M | Buy |
1,713,176
+112,563
| +7% | +$2.38M | 0.84% | 32 |
|
|
2021
Q1 | $44.9M | Buy |
1,600,613
+37,744
| +2% | +$1.06M | 1% | 29 |
|
|
2020
Q4 | $40.6M | Buy |
1,562,869
+696,188
| +80% | +$18.1M | 0.93% | 30 |
|
|
2020
Q3 | $32.2M | Buy |
866,681
+15,228
| +2% | +$566K | 0.8% | 30 |
|
|
2020
Q2 | $43.7M | Buy |
851,453
+39,761
| +5% | +$2.04M | 1% | 26 |
|
|
2020
Q1 | $25.6M | Buy |
811,692
+773,238
| +2,011% | +$24.4M | 0.65% | 30 |
|
|
2019
Q4 | $2.29M | Buy |
+38,454
| New | +$2.29M | 0.05% | 63 |
|